# The Effect of E-EPA on Circulating LDL and Plasma Lipid Metabolism

> **NCT04152291** · NA · COMPLETED · sponsor: **Wihuri Research Institute** · enrollment: 68 (actual)

## Conditions studied

- Atherosclerosis
- Low-density Lipoproteins Aggregation Susceptibility
- Low-density Lipoprotein Lipid Composition
- Cardiovascular Diseases

## Interventions

- **DIETARY_SUPPLEMENT:** Ethyl-Eicosapentaenoic Acid (E-EPA)

## Key facts

- **NCT ID:** NCT04152291
- **Lead sponsor:** Wihuri Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-12
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2025-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04152291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04152291, "The Effect of E-EPA on Circulating LDL and Plasma Lipid Metabolism". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT04152291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*